GoldTech logo

GoldTech

Asia, Beijing, China, Beijing

Description

GoldTech is an investment firm.

Investor Profile

GoldTech has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GoldTech frequently co-invest with?

Yuanta Financial Holdings Group
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
China Universal Asset Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Center Ventures
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Chengwei Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
99Fund
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by GoldTech?

TOT BIOPHARM

Suzhou, Jiangsu, China

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceutical
Series BAug 8, 2018
Amount Raised: $102,000,000